# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, an...
Goldman Sachs urges investors to diversify geographically due to high concentration in US tech stocks, with Japan, healthcare, ...
Microplastics are small plastic fragments found everywhere and can cause harm to human health. Boiling and filtering tap water ...
A group of stocks, which Goldman Sachs dubbed the "Granolas," accounted for 50% of gains of the Stoxx Europe 600 Index ...
Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potenti...
Nestle S.A. (OTC: NSRGY) CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Co...
With health and wellness becoming increasingly popular in the United States, it’s no surprise that weight-loss drugs like Ozemp...
Nestle SA (OTCPK: NSRGY) reported a